American College of Surgeons Appoints Weill Cornell Medicine Physicians to High Positions

Dr. Fabrizio Michelassi

Dr. Fabrizio Michelassi

Two Weill Cornell Medicine physicians have attained leadership positions in the American College of Surgeons.

Dr. Fabrizio Michelassi, chairman of the Department of Surgery and the Lewis Atterbury Stimson Professor of Surgery at Weill Cornell Medicine, has been elected to the Board of Regents of the college. Dr. Barbara Bass, a professor of surgery at Weill Cornell Medicine and the John F. and Carolyn Bookout Distinguished Presidential Chair at Houston Methodist Hospital, has been named president-elect of the college; she will serve as president after its next Clinical Congress.

Founded in 1913, the American College of Surgeons aims to improve the quality of care for surgical patients by setting high standards for surgical education and practice. Its leadership includes a 24-member Board of Regents – elected by a Board of Governors – which includes the college president.

"Election to the Board of Regents is a true honor, and I feel tremendously privileged to be elected,” Dr. Michelassi said. “More importantly, this new appointment is an opportunity for me to continue to be part of an organization dedicated to the mission of ‘improving the care of the surgical patient and to safeguarding standards of care in an optimal and ethical environment,’” he said, quoting the mission statement of the American College of Surgeons.

A fellow of the college since 1987, Dr. Michelassi recently ended a two-year term as chair of the Board of Governors. As a member of the Board of Governors since 2010, Dr. Michelassi has served on its Committee on Surgical Infections, Committee on Socioeconomic Issues and the Ad Hoc Committee to Restructure the Board of Governors. His clinical interest lies in the surgical treatment of gastrointestinal and pancreatic cancers, as well as inflammatory bowel disease.

Dr. Barbara Bass

Dr. Barbara Bass

Dr. Bass, who serves as the chair of the Department of Surgery at Houston Methodist Hospital and as executive director of the Methodist Institute for Technology Innovation and Education, has been a fellow of the college since 1988. Her interests are in surgical education, computational surgery, and breast and endocrine surgery. She previously served as chair of the college’s Board of Governors and as a regent, and was recognized with the Distinguished Service Award in 2013.

“My first independent research funding came from the American College of Surgeons in the form of a Career Development Award nearly 30 years ago,” she said. “That small grant truly helped launch my academic career and subsequent three decades as a funded investigator. I am honored to have the chance to pay back, in service, that long-ago investment. The college is the leading surgical organization in the world to support surgical education and to create programs that foster excellence in delivering surgical care. I’m astonished by the honor to lead this remarkable group.”

Featured Image: 
Type of News: 
Awards & Honors
Dr. Fabrizio Michelassi Dr. Barbara Bass
Clinical Service: 
General Surgery
Highlight this Story: 

Two Weill Cornell Medicine Partners On 'Best Hospitals' Honor Roll


Two of Weill Cornell Medicine's academic partners — NewYork-Presbyterian and Houston Methodist Hospital — are among the nation's elite hospitals, landing spots on U.S. News and World Report's 2016-17 "Best Hospitals" Honor Roll. The annual rankings, published Aug. 2, make Weill Cornell Medicine the rare medical school to have more than one affiliated hospital on the prestigious list.

Only Harvard Medical School also has two affiliates on this year's Honor Roll.

"We congratulate NewYork-Presbyterian and Houston Methodist for our peers' recognition of the outstanding care they provide. With nearly 5,000 hospitals considered, this is no small feat, and we are incredibly proud to partner with two Honor Roll hospitals that enhance patients' lives," said Weill Cornell Medicine Interim Dean Augustine M.K. Choi.

The national rankings use data on patient safety, death rates and hospital reputation. When compiling the 27th annual Honor Roll list, U.S. News took into account both its national rankings and its procedure and condition ratings, which were added last year and include nine procedures, ranging from hip replacement to heart bypass.

Out of 4,667 hospitals eligible for rankings, NewYork-Presbyterian was ranked No. 6 in the United States and No. 1 in the New York metro area. NewYork-Presbyterian is also ranked in the top 10 in nine out of 16 specialties this year.

"We are extremely pleased to be recognized as the leading hospital in New York and among the best in the nation for the 16th consecutive year," said Dr. Steven Corwin, president and CEO of NewYork-Presbyterian. "Our collective goal — together with Columbia University Medical Center and Weill Cornell Medicine — is to continue to provide the most innovative and compassionate care to patients and their families in the New York metropolitan area and throughout the globe. Patients are — and will always be — our No. 1 priority. We pride ourselves on offering the most advanced treatment options and technology, powered by leading clinical research by our world-renowned physicians and experts. We could not have achieved this honor without our dedicated staff who continues to accomplish amazing feats in healthcare."

At No. 19, Houston Methodist Hospital regained its position in the Top 20 for the first time since 2009. It remains the top hospital in Texas for the fifth straight year, according to the rankings.

"Making the Honor Roll is a tremendous achievement for our physicians, nurses and employees who give the best of themselves every day to our patients," said  Dr. Marc Boom, president and CEO of Houston Methodist. "This is validation that we are leading medicine, providing our community the highest quality medical care, research and education for almost 100 years."

Featured Image: 
Type of News: 
News from WCM
Highlight this Story: 

Weill Cornell Medicine Launches Collaborative Bioethics Fellowship


Weill Cornell Medicine, NewYork-Presbyterian, and Houston Methodist have established a new collaborative fellowship program to create highly trained bioethicists. Nurturing leaders in this field, program leaders say, will improve patient care by providing guidance to clinicians navigating ethically difficult situations and offering patients expert support.

Four institutions – Weill Cornell Medicine, NewYork-Presbyterian, Houston Methodist, and Baylor College of Medicine – are coming together to form the New York-Houston Medical Ethics Consortium under which the New York based Medical Ethics Fellowship Program will operate, in addition to a parallel Houston-based fellowship sponsored by Houston Methodist and Baylor College of Medicine's Center for Medical Ethics and Health Policy. The collaboration presents an opportunity to unite faculty, knowledge and experience to create future leaders in the bioethics community.

"Clinical ethicists help level the playing field. They help elucidate the truth and empower patients and families in dialogue with their doctors," said Dr. Michael Stewart, co-chairman of the consortium, vice dean and chairman of Otolaryngology – Head and Neck Surgery at Weill Cornell Medicine and otolaryngologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center. "This ensures that our patients receive the very best care that is aligned with their values and concerns. Our collaboration with NewYork-Presbyterian, Houston Methodist and Baylor will greatly advance this work, and we couldn't be more thrilled to capitalize on this incredible opportunity."

"I am extremely pleased to see how significant and nationally ranked institutions are able to coordinate and unite their resources in better serving our patients and their families. There has never been a stronger need for bioethics than today, especially where it concerns clinicians and patients alike in searching for and in receiving the best care possible," said the Rev. Charles Millikan, co-chairman of the consortium and vice president for spiritual care and values integration at Houston Methodist.

Under the leadership of Dr. Joseph J. Fins, chief of the Division of Medical Ethics at Weill Cornell Medicine, the American Society for Bioethics and Humanities began in 2011 to develop a quality-attestation process to certify bioethicists, but there is no accreditation process in place yet.

"It's essential that an activity with so much consequence for patient welfare is well regulated and that the people carrying out clinical ethics have the proper training," said Dr. Fins, director of the Weill Cornell Medicine-NewYork-Presbyterian-Houston Methodist Medical Ethics Fellowship Program. Dr. Fins is the E. William Davis, Jr., M.D. Professor of Medical Ethics and a professor of medicine, medicine in psychiatry, healthcare policy and research, and medical ethics in neurology at Weill Cornell Medicine and director of medical ethics at NewYork-Presbyterian/Weill Cornell.

"It is therefore critical to develop more highly trained bioethicists in this field," Dr. Fins said. For example, how should a clinician approach a patient who needs medical attention but refuses care? Or a patient who needs to make a treatment decision but lacks the cognitive faculties to do so? Just as an internist would call a surgeon to perform a specialized procedure, so should a physician be able to consult with a qualified bioethicist on an ethically complex case.

Both the New York-based and Houston-based medical ethics fellowships were created to help achieve these goals through rigorous bioethics training, since the certification process is still in development. The consortium offers fellows from both programs a two-year joint curriculum that will include bimonthly videoconferences, half of which will be faculty-taught seminars and half involving the presentation of past cases, current work, and journal articles by the fellows. They also will attend ethics committee meetings, teach medical students and residents, and complete a mentored capstone research project. The New York-based fellowship will begin on July 1 and the recruitment process is currently underway.

In addition to the content and format, the contrasting geographic climates in which the fellowships take place will serve as a valuable learning tool.

"By drawing on the diversity of bioethics expertise in the two cities and exposing fellows to the jurisdictional and cultural distinctions of hospitals in different geographic regions, the consortium offers a unique training program for clinical ethics fellows," said Dr. Amy McGuire, director of the Baylor College of Medicine-Houston Methodist Medical Ethics Fellowship Program and the Leon Jaworski Professor of Biomedical Ethics and director of the Center for Medical Ethics and Health Policy at Baylor College of Medicine.

Through useful geographic positioning and a rigorous curriculum, officials hope the fellowship will launch its graduates as expert leaders in the emerging yet critically important field of medical ethics to ultimately improve patient care.

"So much of what we do in medicine involves technical decisions, but it's imperative that we take human emotions and dignity into account when treating patients," said Dr. Laura Forese, executive vice president and chief operating officer of NewYork-Presbyterian. "Ethics helps to give everybody the voice that they deserve."

Featured Image: 
Dr. Joseph J. Fins
Type of News: 
News from WCM
Highlight this Story: 

Sanford I. Weill Retires as Chair of the Weill Cornell Board of Overseers After 20 Years of Transformative Leadership


Jessica M. Bibliowicz, Successful Business Executive, Named New Chair of the Board

NEW YORK (December 9, 2014) — After 20 years of bold and visionary leadership that has transformed Weill Cornell Medical College into a global healthcare enterprise, Sanford I. Weill will retire as chair of the Weill Cornell Board of Overseers on Jan. 1. Jessica M. Bibliowicz, a successful entrepreneur in the financial services business for nearly three decades, who has served on the Board of Overseers for the past decade, will succeed Mr. Weill, the new chair emeritus.

Jessica M. Bibliowicz and Sanford I. Weill

Jessica M. Bibliowicz and Sanford I. Weill. All photos: John Abbott

The transition comes as the 116-year-old medical college embarks on a new chapter that builds upon the landmark successes Mr. Weill has realized in his two decades as chair. His enduring dedication to the institution that bears his name has resulted in an unprecedented expansion that is exemplified in Weill Cornell's excellence in medical education, biomedical research and clinical care. In collaboration with medical college leadership, Ms. Bibliowicz will help lead Weill Cornell as it continues to break new ground in New York and abroad by expanding its clinical enterprise and forging public-private partnerships that accelerate groundbreaking scientific discoveries for patients. Working closely with Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College, Ms. Bibliowicz will help guide its transformation of medical education and drive dialogue on innovative healthcare delivery models that optimize the value and quality of patient care.

"When I joined the Board of Overseers more than 30 years ago, I was driven to try and make a difference in the world," Mr. Weill said. "It's truly humbling to see just how much of an impact Weill Cornell has had around the globe, and I believe we are poised to thrive far into the future. Weill Cornell Medical College is more to me than just an esteemed medical school — the people here are my extended family. I could think of no one better than Jessica to shepherd Weill Cornell into the next stage of its evolution."

"It's an honor and privilege to be able to support Weill Cornell Medical College's tremendous efforts to educate, innovate and heal," Ms. Bibliowicz said. "As a Cornell University alum, it's especially meaningful to me to try and help take this distinguished institution to the next level of excellence in New York and beyond. Our ever-changing healthcare landscape has sparked exciting opportunities to help shape national conversation, and I'm eager to work with Dr. Glimcher and the Board of Overseers as we strive to improve and prolong human health."

Dr. Laurie H. Glimcher, Sanford I. Weill and Jessica M. Bibliowicz

In the three decades he has served on the Board of Overseers and in the two decades he has been chair, Mr. Weill has been much more than a governing force. His benevolence and unwavering resolve to ensure a healthier future has touched every program area at Weill Cornell, establishing the medical school as an innovator in basic, clinical and translational research, and forging a new paradigm for global engagement and medical education.

Under Mr. Weill's leadership, the medical college has built bridges nationally and abroad. Weill Cornell forged an affiliation with Houston Methodist in Texas and, with Cornell University, established a medical school in Doha, Qatar. Since its inception in 2002, Weill Cornell Medical College in Qatar, which offers a Cornell University medical degree, has created 181 new doctors who have continued their graduate medical training in residencies and clinical research at outstanding institutions in the United States and Qatar. The Weill Cornell Qatar location has also established a world-class biomedical team and contributed to Qatar's goal of becoming a knowledge-based economy. In addition, Weill Cornell in 2007 established a formal affiliation with Bugando Medical Centre and the Weill Bugando University College of Health Sciences in Mwanza, Tanzania, named in recognition of the Weills' support. Weill Bugando has graduated an average of 100 new doctors every year for the past seven years in Mwanza, expanding Tanzania's core of providers who are empowered to deliver the best patient care, despite a resource-limited setting. This unique educational partnership has spurred new possibilities for cultural exchange, providing medical students at Weill Cornell in New York and residents at NewYork-Presbyterian Hospital with the opportunity to spend a month or two in Mwanza practicing medicine the way it used to be, with limited modern technology. They return to New York with a greater sense of gratification that reaffirms their commitment to global health and a career in academic medicine.

In recognition that building a healthier future also requires training an exceptional cadre of new doctors and scientists, Mr. Weill and his wife Joan in 1992 established the Joan and Sanford I. Weill Education Center, the heart of the medical college's education program, with their first gifts to Weill Cornell. The Weill Education Center comprises the Weill Auditorium and 20 classrooms and teaching laboratories outfitted with modern audio-visual, networking and wireless technology to provide the next generation of medical professionals with the best environment for learning.

Sanford I. Weill

In 2007, Weill Cornell opened the Weill Greenberg Center in New York City, the medical college's flagship and award-winning ambulatory care center, and in January opened the adjacent Belfer Research Building, a transformative 18-story, state-of-the-art facility that ensures that the medical college remains at the forefront of scientific discovery. Their proximity to each other ensures that breakthroughs made in the laboratory can be rapidly applied to patient care as improved treatments and therapies. Weill Cornell has successfully recruited some of the world's leading physicians and scientists to conduct this translational research. Last year, the Weills established the Weill Center for Metabolic Health, which strives to understand the basic biology and genetics of diabetes, obesity and metabolic syndrome, and translate discoveries into next-generation therapeutic approaches. Weill Cornell is conducting a national search for a renowned scientist to lead these efforts.

A self-made man who exemplifies the philosophy of leading by example, Mr. Weill, Mrs. Weill and the Weill Family Foundation have generously given more than $550 million in gifts to support Weill Cornell Medical College. They include a groundbreaking $100 million gift in 1998 — at the time the largest in Cornell University's history — a second $100 million gift in 2002, a $250 million gift in 2007 and another $100 million gift in 2013 to establish the Weill Center for Metabolic Health, as well as the Joan and Sanford I. Weill and the Weill Family Foundation Global Health Research Laboratories. In honor and appreciation of their unparalleled dedication and enduring commitment, the institution in 1998 was renamed Weill Cornell Medical College. With an additional gift of $50 million to Cornell University, the Weills' total giving tops $600 million.

The Weills' altruism inspired and galvanized Weill Cornell's numerous, loyal donors to support the medical college. In Mr. Weill's 20 years as chair, the medical college has raised $3 billion. Earlier this year, Weill Cornell celebrated the Weills' legacy by naming its department of medicine the Joan and Sanford I. Weill Department of Medicine.

"What Sandy has done for Weill Cornell, New York and the world is just breathtaking — it's a labor of love that will touch the lives of generations," Dr. Glimcher said. "His unwavering leadership, profound magnanimity and steadfast resolve to enhance medical education, advance discoveries and enrich clinical care is his lasting legacy. Jessica is an outstanding choice to assume Sandy's mantle and steer Weill Cornell into the future. I couldn't be more thrilled for what's to come."

"Sandy is a businessman, entrepreneur, philanthropist, visionary leader, chairman emeritus of Citigroup, Cornell alumnus and my good friend," said Cornell University President David Skorton. "As chair of the Board of Overseers of Weill Cornell Medical College, he has nurtured the college's growth, guided its progress and expanded its capacity for rigorous medical education, path-breaking research and superb clinical care — to the enormous benefit of our students, faculty, researchers and patients. I am delighted that Jessica Bibliowicz, who has provided exemplary leadership to the university and the medical college, has agreed to take on this new role as chair of the Board of Overseers."

"It is impossible to overstate the impact that Sandy has had on Weill Cornell Medical College, and on the whole of Cornell University, during his time as chair of the Board of Overseers," said Robert Harrison, chair of the Cornell University Board of Trustees. "He is someone who can not only articulate a strong and inspirational vision, but also bring people together to do what it takes to make the vision a reality. Although I will miss working with Sandy, I am very much looking forward to working with Jessica in her new role. She has been a very effective trustee and overseer for many years and clearly has the talent and energy to lead the Board of Overseers and the medical school to new heights."

About Jessica M. Bibliowicz

A Cornell University graduate in 1981 and after working 18 years in financial services, Ms. Bibliowicz became CEO of National Financial Partners in 1999, a financial services firm that specializes in benefits and wealth management. The company went public in 2003 and was sold to Madison Dearborn in 2013. Ms. Bibliowicz joined the Weill Cornell Board of Overseers in 2004. She is also a member of the Cornell University Board of Trustees and a member of the Cornell NYC Tech Campus Task Force. Currently, Ms. Bibliowicz is a senior advisor at Bridge Growth Partners and serves on the board of directors of Sotheby's(NYSE: BID); Realogy (NYSE: RLGY); and the Asia Pacific Fund (NYSE: APB). She is a board director/trustee of Prudential Insurance Funds and is also on the board of Jazz at Lincoln Center.

Weill Cornell Medical College

Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, Cornell University is the first in the U.S. to offer a M.D. degree overseas. Weill Cornell is the birthplace of many medical advances — including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with Houston Methodist. For more information, visit

Featured Image: 
Jessica M. Bibliowicz
Type of News: 
Press Releases
Jessica M. Bibliowicz Sanford I. Weill Dr. Laurie H. Glimcher
Highlight this Story: 
External Affairs

State of the Medical College: Weill Cornell Rises to Health Care Challenges


Academic medical centers face an uncertain future, especially as federal research funds continue to shrink, but Weill Cornell Medical College is poised not only to thrive, but to lead the way in providing excellent education, research and clinical care.

In Dr. Laurie H. Glimcher's annual State of the Medical College address — her second as the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College — she said that Weill Cornell is positioned for a prosperous future by evolving with the ever-changing health care environment.

Dr. Laurie H. Glimcher; State of the Medical College address

Dr. Laurie H. Glimcher delivers annual State of the Medical College address on Dec. 4. Photo credit: Ira Fox

Standing in front of a crowded Uris Auditorium on Dec. 4, Dr. Glimcher reviewed the medical college's accomplishments over the past year and shared her goals for 2014 — among them, establishing a new medical school curriculum, strengthening the biomedical research enterprise, and expanding Weill Cornell's footprint in clinical care.

"I think that we have made some significant progress," Dr. Glimcher said. "I think we are already on our way to putting many of these agendas into action here at Weill Cornell — thanks to the help and commitment and passion of all of you."

While Weill Cornell is in the black, it's not immune to the challenges facing all academic medical centers, she said. Research funding from the National Institutes of Health has plummeted 20 percent over the past decade, with the $1.7 billion in cuts enacted this spring through sequestration inflicting even greater pain on scientists who can no longer obtain research grants. It's clear, Dr. Glimcher said, that the academic medical centers can no longer rely solely on traditional funding streams for their work.

To counteract Washington belt-tightening, Dr. Glimcher said the medical college will continue to seek philanthropy and build public-private partnerships to spur advances in each facet of Weill Cornell's mission.

"We need more resources because we have big plans in medical education, in research and in clinical expansion," she said.

Reimagining Medical School Curriculum

To prepare the next generation of physicians and scientists, Weill Cornell faculty have spent the last few years rewriting the medical school curriculum, which was last updated in 1996. Leadership will pilot the new educational blueprint — which will accelerate students' access to the clinic by a semester — in January with full roll-out next fall.

"Our curriculum has trained our students well, but needed to be reinvigorated and altered to fit the very rapidly changing health care environment and very rapidly changing research environment," Dr. Glimcher said.

This reform will enhance Weill Cornell's education program, which continues to attract the best and brightest students, Dr. Glimcher said. The diverse Class of 2017 — 19 percent of its students are from groups underrepresented in medicine — has the highest mean Medical College Admission Test score ever recorded at the medical college, and boasts 18 M.D.-Ph.D. students. At Weill Cornell Medical College in Qatar, nine of the 41 students in this year's entering class have successfully completed the medical college's pre-pre-med and pre-med programs.

The Weill Cornell Graduate School of Medical Sciences, led by new Dean Dr. Gary Koretzky, accepted 56 students from 653 applicants. Some 13 percent are from groups underrepresented in medicine. In the Tri-Institutional M.D.-Ph.D. program, ranked first among M.D.-Ph.D. programs nationally for diversity, 24 percent of students enrolled in the program come from groups underrepresented in medicine. Last winter the program received a perfect score in its NIH Medical Scientist Training Program renewal grant application.

Expanding Weill Cornell's Biomedical Enterprise

Much of the medical college's successes are entwined with the prowess of its faculty, Dr. Glimcher said. Over the past two years, Weill Cornell has added 32 leading scientists to its ranks — among them nine senior recruits — who together will advance basic, clinical and translational research along with clinical care at the medical college.

She highlighted the backgrounds of three new leaders at Weill Cornell — Dr. Koretzky, who is also senior associate dean for research, Dr. Augustine Choi, chairman of the Department of Medicine, and Dr. Hugh Hemmings, chairman of the Department of Anesthesiology.

Weill Cornell is fortunate to already have a first-rate biomedical enterprise, Dr. Glimcher said, which will be enriched with the opening of the Belfer Research Building next month and efforts to recruit more of the world's leading lights — all possible due to the generosity of Weill Cornell benefactors.

To advance its mission of bringing the most advanced care to patients, Weill Cornell has established nearly a dozen interdisciplinary centers and institutes — some in partnership with NewYork-Presbyterian Hospital — that transform the paradigm for high-impact biomedical research. These hubs — the Cancer Center at Weill Cornell and NewYork-Presbyterian Hospital, the Feil Family Brain and Mind Research Institute and the Institute for Precision Medicine among them — are charged with fostering collaboration between basic and translational scientists and clinicians to accelerate the application of groundbreaking discoveries made in the lab to innovative therapies for patients.

But drug development cannot be done in a vacuum. It is crucial to get the private sector involved to help ensure that findings in academic labs are translated into treatments, Dr. Glimcher said.

"Academe is very good at biology and target discovery and proof of principle," she said. "We're not so great in medicinal chemistry and that's where pharma is very strong."

To that end, Weill Cornell, Memorial Sloan-Kettering Cancer Center and The Rockefeller University joined forces with pharmaceutical company Takeda this fall in forming the Tri-Institutional Therapeutics Discovery Institute, which is tasked with expediting early-stage drug discovery into innovative treatments and therapies. The Tri-I TDI has just selected Dr. Michael Foley as director, and Takeda's scientists will arrive in March.

As the Tri-I TDI embarks on its work, Larry Schlossman, managing director of BioPharma Alliances and Research Collaborations at Weill Cornell, continues to develop partnerships between pharmaceutical companies and the medical college.

Providing Top-Notch Clinical Care

These initiatives would be for naught were they not infused with Weill Cornell's primary mission: "to keep the patient at the center of everything we do," Dr. Glimcher said. Discoveries made by basic scientists are increasingly being applied by physicians as Weill Cornell expands its clinical presence.

In March, the medical college and the Weill Cornell Physician Organization opened a new, comprehensive medical practice on Manhattan's West Side, offering imaging, primary care and high-demand specialty services to children and adults — all under one roof. And in July, when New York Downtown Hospital merged with NewYork-Presbyterian Hospital to become NewYork-Presbyterian/Lower Manhattan; the 140 physicians on staff became credentialed members of the Weill Cornell faculty, as well as members of the physician organization. Both practices create a bridge between Weill Cornell's world-class physicians on the Upper East Side with areas in Manhattan that previously had limited access to the high-quality patient care that the academic medical center provides.

"I think Weill Cornell and NewYork-Presbyterian Hospital are known for providing absolutely outstanding clinical care, both here and abroad," Dr. Glimcher said.

These efforts in clinical care, medical education and biomedical research continue to occur in partnership with Cornell University, CUNY Hunter College and Houston Methodist. And Weill Cornell's global initiatives in places like Weill Bugando in Tanzania, Gheskio in Haiti and Weill Cornell Medical College in Qatar remain strong, Dean Glimcher said.

"I think the experiment in Qatar started by Dean [Antonio M.] Gotto has really proven itself to be a success in terms of the quality of young people we are training to be physicians," she said.

The strength of Weill Cornell's mission is what sets Weill Cornell apart, Dr. Glimcher said, and is what will keep the medical college thriving.

"I want to thank all of you, faculty, staff, administration, students for your commitment to and passion for this really wonderful institution," she said. "It's been a great privilege to work with all of you over the last year, and I think the best is yet to come."

Featured Image: 
state of the medical college address; Dr. Laurie Glimcher
Type of News: 
News from WCM
Highlight this Story: